Rani Therapeutics Holdings, Inc. — Form D

Rani Therapeutics Holdings, Inc. of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-10. The offering totals $60.3M, of which $60.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-11-10
• Form: D
• Accession: 0001231919-25-000450
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $60.3M
• Amount sold: $60.3M
• Investors: 15
• Date of first sale: 2025-10-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-563500

Issuer

• Name: Rani Therapeutics Holdings, Inc.
• CIK: 0001856725
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Incorporated: 2021
• Address: 2051 RINGWOOD AVENUE, SAN JOSE, CA, 95131
• Phone: (408) 457-3700

Officers, directors & promoters (10)

More

• CIK 1856725 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search